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Background
Many infected subjects acquire 2 or more strains of HIV-1,
in some cases both CTL escape-mutants (EM) and wild-
type (WT) variants. Eventual reversion to WT reflects fitter
WT virus in vivo. However, reported reversion rates vary
widely. Understanding reversion (and how to maintain
unfit EM variants) should facilitate better approaches to
HIV-1 control. We hypothesised that co-transmission of
WT virus in the infecting inoculum leads to rapid rever-
sion and more pathogenic infections.
Methods
A quantitative RT-PCR simultaneously measures WT and
EM viral loads at the Mane-A*10-restricted SIV Gag
KP9164-172 CTL epitope in pigtail macaques. Reversion
of the K165R EM viruses from 5 SIV and SHIV inocula
were assessed in 15 naïve A*10-ve macaques.
Results
Infection with isolates containing ≥10% WT SIVmac239,
SHIVmn229 or SHIVSF162P3 all show rapid growth of
both WT and EM virus during acute infection and EM
virus decays rapidly thereafter. Conversely, delayed rever-
sion occurs in animals infected with a SIVmac239 K165R
clone, and ≤4% WT SHIVs. Further, the reversion rate is
proportional to target CD4 T cell number. Importantly,
EM inocula with delayed reversion are less pathogenic,
showing reduced peak and set point viral load compared
to those infected with ≥10% WT in the inocula and show-
ing rapid reversion (P = 0.0094, P = 0.0072 respectively).
Conclusion
When infected with 2 viruses (both EM and >10%WT),
rapid outgrowth of WT virus occurs during acute infec-
tion. Delayed reversion to WT results if only EM virus ini-
tiates the infection, primarily due to some target cell
depletion by the EM virus during acute infection prior to
the appearance of WT virus. The delay in reversion, where
acute viremia is primarily the less fit EM virus, results in a
significant reduction in VL and will delay disease. This has
implications for vaccine strategies to maintain weaker EM
viruses in new hosts.
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